Aprazer Healthcare Launched ABIRAKAST (Abiraterone acetate ) which is a medication used to treat prostate cancer specifically it is used together with corticosteroid for metastatic castration-resistant prostate cancer (mCRPC) and metastatic high-risk castration-sensitive prostate cancer (mCSPC)
Aprazer Healthcare Launched ABIRAKAST
27
Jan